0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 41-60 of 620 Articles
Editorial | 
Peter M. Nilsson, MD, PhD; Fredrik H. Nystrom, MD, PhD
JAMA. 2014;312(8):795-796. doi:10.1001/jama.2014.10058.

Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2014;312(8):779. doi:10.1001/jama.2014.10040.

Original Investigation |  FREE
Richard J. McManus, FRCGP; Jonathan Mant, MD; M. Sayeed Haque, PhD; et al.
JAMA. 2014;312(8):799-808. doi:10.1001/jama.2014.10057.
Includes: Supplemental Content

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(7):684-686. doi:10.1001/jama.2014.9253.

news@JAMA | 
JAMA. 2014;312(7):686. doi:10.1001/jama.2014.10096.

Viewpoint | 
Ulrike Bingel, MD, PhD; For the Placebo Competence Team
JAMA. 2014;312(7):693-694. doi:10.1001/jama.2014.8342.

Review | 
Anita Kohli, MD, MS; Ashton Shaffer, BA; Amy Sherman, MD; et al.
JAMA. 2014;312(6):631-640. doi:10.1001/jama.2014.7085.
Includes: CME, Supplemental Content

News From the Centers for Disease Control and Prevention | 
JAMA. 2014;312(6):591. doi:10.1001/jama.2014.9326.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;312(5):477. doi:10.1001/jama.2014.9731.

Editorial | 
Michael S. Saag, MD
JAMA. 2014;312(4):347-348. doi:10.1001/jama.2014.7735.

Editorial | 
Bradley M. Mathers, MBChB, MD; David A. Cooper, MD, DSc
JAMA. 2014;312(4):349-350. doi:10.1001/jama.2014.8606.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(4):328. doi:10.1001/jama.2014.8885.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(4):328. doi:10.1001/jama.2014.9118.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(4):328. doi:10.1001/jama.2014.9120.

Clinical Trials Update | 
Anita Slomski
JAMA. 2014;312(4):327. doi:10.1001/jama.2014.9150.

JAMA Patient Page |  FREE
Jill Jin, MD, MPH
JAMA. 2014;312(4):452. doi:10.1001/jama.2014.8191.
Includes: Supplemental Content

Special Communication |  FREE
Jeanne M. Marrazzo, MD, MPH; Carlos del Rio, MD; David R. Holtgrave, PhD; et al.
JAMA. 2014;312(4):390-409. doi:10.1001/jama.2014.7999.
Includes: CME, Supplemental Content

Special Communication |  FREE
Huldrych F. Günthard, MD; Judith A. Aberg, MD; Joseph J. Eron, MD; et al.
JAMA. 2014;312(4):410-425. doi:10.1001/jama.2014.8722.
Includes: Supplemental Content

Viewpoint | 
Anthony S. Fauci, MD; Hilary D. Marston, MD, MPH; Gregory K. Folkers, MS, MPH
JAMA. 2014;312(4):335-336. doi:10.1001/jama.2014.4754.

Medical News & Perspectives | 
Rebecca Voelker, MSJ
JAMA. 2014;312(3):221. doi:10.1001/jama.2014.8845.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Internal Medicine
Original Investigation  | 
The Strength of Association Between Surrogate End Points and Survival in Oncology A Systematic Review of Trial-Level Meta-analyses
Vinay Prasad, MD, MPH; Chul Kim, MD, MPH; Mauricio Burotto, MD; et al.
JAMA Internal Medicine
Original Investigation  | 
Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis A Systematic Review and Meta-analysis
Danilo Di Bona, MD, PhD; Antonella Plaia, PhD; Maria Stefania Leto-Barone, MD, PhD; et al.
JAMA Internal Medicine
Original Investigation  | 
Allopurinol Use and Risk of Fatal Hypersensitivity Reactions A Nationwide Population-Based Study in Taiwan
Chien-Yi Yang, BS; Chi-Hua Chen, MS; Shin-Tarng Deng, MS; et al.
JAMA Internal Medicine
Evidence to Practice  | 
Comparative Clinical Effectiveness and Value of Novel Interferon-Free Combination Therapy for Hepatitis C Genotype 1 Summary of California Technology Assessment Forum Report
Jeffrey A. Tice, MD; Harinder S. Chahal, PharmD, MSc; Daniel A. Ollendorf, PhD